Evidence map›Paper›PMID 40688610›Full record

ArticleThe annals of applied statistics2024

UTILIZING A CAPTURE-RECAPTURE STRATEGY TO ACCELERATE INFECTIOUS DISEASE SURVEILLANCE.

Lin Ge, Yuzi Zhang, Lance Waller, Robert Lyles

Abstract read
In one paragraph

Article in The annals of applied statistics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lin GeDepartment of Biostatistics and Bioinformatics, Emory University.ORCID 0000-0002-8180-9615
Yuzi ZhangDepartment of Biostatistics and Bioinformatics, Emory University.ORCID 0000-0003-1805-6910
Lance WallerDepartment of Biostatistics and Bioinformatics, Emory University.ORCID 0000-0001-5002-8886
Robert LylesDepartment of Biostatistics and Bioinformatics, Emory University.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Registering Cancer Recurrences in the Georgia Cancer RegistryR01CA234538 · NCI · EMORY UNIVERSITY · PI LASH, TIMOTHY L., WARD, KEVIN C · 2019 to 2024
$2.8M
Refined Capture-Recapture Methods for Surveilling Cancer RecurrenceR01CA266574 · NCI · EMORY UNIVERSITY · PI LYLES, ROBERT H, WALLER, LANCE A · 2022 to 2025
$1.4M
NCATS NIH HHS UL1 TR002378NCI NIH HHS R01 CA234538NCI NIH HHS R01 CA266574NIAID NIH HHS P30 AI050409
6 · The paper itself

Abstract

Monitoring key elements of disease dynamics (e.g., prevalence, case counts) is of great importance in infectious disease prevention and control, as emphasized during the COVID-19 pandemic. To facilitate this effort, we propose a new capture-recapture (CRC) analysis strategy that adjusts for misclassification stemming from the use of easily administered but imperfect diagnostic test kits, such as rapid antigen test-kits or saliva tests. Our method is based on a recently proposed "anchor stream" design, whereby an existing voluntary surveillance data stream is augmented by a smaller and judiciously drawn random sample. It incorporates manufacturer-specified sensitivity and specificity parameters to account for imperfect diagnostic results in one or both data streams. For inference to accompany case count estimation, we improve upon traditional Wald-type confidence intervals by developing an adapted Bayesian credible interval for the CRC estimator that yields favorable frequentist coverage properties. When feasible, the proposed design and analytic strategy provides a more efficient solution than traditional CRC methods or random sampling-based bias-corrected estimation to monitor disease prevalence while accounting for misclassification. We demonstrate the benefits of this approach through simulation studies and a numerical example that underscore its potential utility in practice for economical disease monitoring among a registered closed population.

Indexed as

Credible intervalmisclassificationnonrepresentative samplingsensitivityspecificity

Identifiers

PMID40688610
PMCPMC12273866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.